Nurix Therapeutics | 4:持股变动声明-董事 Kapur Anil
Nurix Therapeutics | 3:首次持股声明-董事 Kapur Anil
Nurix Therapeutics | 4:持股变动声明-高管 Ring Christine
Nurix Therapeutics | 4:持股变动声明-高管 Ring Christine
Nurix Therapeutics | 4:持股变动声明-高管 Ring Christine
Nurix Therapeutics | 4:持股变动声明-高管 Ring Christine
Nurix Therapeutics | 4:持股变动声明-高管 van Houte Hans
Nurix Therapeutics | 4:持股变动声明-高管 van Houte Hans
Nurix Therapeutics | 4:持股变动声明-高管 Ring Christine
Nurix Therapeutics | 4:持股变动声明-高管 Hansen Gwenn
Nurix Therapeutics | 4:持股变动声明-高管 Ring Christine
Nurix Therapeutics | 4:持股变动声明-高管 van Houte Hans
Nurix Therapeutics | 4:持股变动声明-董事 Kunkel Lori Anne
Nurix Therapeutics | 4:持股变动声明-高管 Ring Christine
Nurix Therapeutics | 4:持股变动声明-高管 van Houte Hans
Nurix Therapeutics | 4:持股变动声明-高管 Ring Christine
Nurix Therapeutics | 4:持股变动声明-高管 Ring Christine
Nurix Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(10.2%)
Nurix Therapeutics | 4:持股变动声明-高管 Ring Christine
Nurix Therapeutics | 4:持股变动声明-高管 Ring Christine
暂无数据
暂无数据